Skip to main content

Table 4 Effective dose for PET/CT protocols with PET and CT contributions*

From: Effective dose estimation for oncological and neurological PET/CT procedures

Diagnostic protocol PET ED
(mSv)
CT part CT ED
(mSv)
Total ED
(mSv)
Torso-11C-CHOL 3.1 ± 0.2 (2.8, 3.3) Torso 10.4 ± 2.2 (5.9, 13.6) 13.5 ± 2.2 (9.2, 16.6)
Torso-18FDG 6.1 ± 1.2 (3.5, 9.5) Torso 10.3 ± 3.8 (5.3, 34.9) 16.5 ± 4.5 (9.7, 42.1)
WB-18FDG 6.1 ± 1.3 (4.6, 10.6) H&Torso 11.9 ± 4.5 (5.2, 21.7) 20.0 ± 5.6 (1.8, 32.7)
Limbs 2.0 ± 0.8 (1.1, 5.1)
HNT-18FDG 5.7 ± 0.8 (4.7, 7.3) Trunk 8.0 ± 2.0 (5.6, 12.7) 15.4 ± 2.8 (12.3, 22.1)
H&N 1.7 ± 0.3 (1.1, 2.1)
Brain-18FDG 5.6 ± 0.6 (4.3, 6.5) Brain 0.73 ± 0.07 (0.59, 0.84) 6.4 ± 0.6 (5.0, 7.2)
Brain-18FDOPA 4.0 ± 0.5 (3.1, 4.5) Brain 0.65 ± 0.08 (0.57, 0.84) 4.6 ± 0.4 (3.9, 5.2)
Brain-11C-MET 4.0 ± 0.8 (2.9, 5.2) Brain 1.22 ± 0.1 (1.0, 1.4) 5.2 ± 0.5 (4.1, 6.5)
Brain-18F-florbetapir 7.0 ± 0.2 (6.6, 7.4) Brain 2.33 ± 0.2 (2.1, 2.8) 9.1 ± 0.4 (8.8, 10.2)
  1. *Values are presented as mean ± SD (minimum, maximum)